Discover how to turn your genomic data to insights in minutes powered by our AI-driven platform, GenomeArc Horizon.
Our genome analytics platform brings unprecedented insights for meaningful diagnosis.
Our Horizon genomic medicine platform is fully automated for whole genome variant interpretations and pathogenicity predictions. The platform provides rapid actionable insights integrating complex phenotype data.
The Horizon platform helps achieve high genetic diagnostic yield and can analyse, interpret and report causal variants in minutes. We use well-curated variant databases and natural language processing (NLP) to understand complex genetic phenotypes.
Automation is at the core of Horizon, as it seamlessly integrates large and phenotypic genome databases with genome variants.
Our variant pathogenicity algorithms validate with high precision using population scaled multi-ethnic clinical genomics datasets.
Horizon platform integrates transcriptomes, proteomes, and other OMICs databases to interpret coded and non-coded genomic variants.
Horizon Genomic Medicine Platform Features
The Horizon platform provides rapid precision diagnostic interpretation for reporting genomic variants and providing actionable therapeutic interventive insights for rare genetic diseases.
Our innovative solutions extracts cryptic phenotypic details to integrate large genomic databases for reporting.
Know MoreFor Cancer and Rare Genetic Diseases
Genome Data Processing:
Impact:
Integrate Custom Phenotypic
Database or Software
Lack of ethnic diversity in single-cell transcriptomics
Perhaps one of the most revolutionary next generation sequencing technologies is single-cell (SC) transcriptomics, which was recognized by Nature in 2013 as the method of the year.
Construction of copy number variation landscape
Copy number variations (CNVs) play a critical role in the pathogenesis of neurodevelopmental disorders (NDD) among children.
Decoding Genetics of Rare Neurodevelopmental Disorders: A Cohort Study Powered by the GenomeArc Horizon Platform
Neurodevelopmental disorders (NDDs) represent a complex web of genetic underpinnings, particularly in ethnically diverse populations with high rates of consanguinity...
Read More
GenomeArc Announces Early Access Program for Horizon Version 2, the Most Comprehensive Multi-Omics Platform for Clinical Genomics
GenomeArc, a pioneering force in genomic technology, is proud to announce the Early Access Program for Version 2 of its Clinical Genetics...
Read More
Horizon Intelligence: Transforming Genomic Diagnosis with Multi-OMICs AI
In the rapidly evolving field of genomics, the need for fast, accurate, and precise variant interpretation has never been greater. As the volume of...
Read MoreWe care about the protection of your data.
Associate Professor,
College of Medicine,
MBRU, Dubai
Founder and CEO,
GenomeArc Inc.
Toronto, Canada
Senior Lecturer,
Biosciences Institute, Newcastle University,
Newcastle Upon Tyne, UK
Associate Professor,
College of Medicine,
Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai
Professor of Medicine,
Faculty of Medicine,
Memorial University, Canada
Director,
Institute of Physiology, Charité - Universitätsmedizin Berlin, Germany
Professor, Associate Scientist,
University of Toronto, Canada
We are a team of geneticist, clinicians, bioinformaticians, software engineers, and ethicists, committed to solving genetic diseases, to advance science and benefit humanity. Our research driven approach is helping us constantly updating and solving the most complex problems in genomic medicine.!
We have global teams supporting customers worldwide and we are headquartered in the wonderful city of Mississauga, Ontario.
GenomeArc Inc. 55 Village Centre Place, Mississauga, ON, L4Z 1V9, Canada
